Category Archives: News

Meet the Mafia gangster the CIA wanted to assassinate Fidel Castro

In the summer of 1960, a former FBI and sometime CIA man named Robert Maheu was handed an important mission by the latter agency — engaging the Mafia to assassinate Cuban leader Fidel Castro. Maheu knew exactly whom to call. The new book “Handsome Johnny: The Life and Death of Johnny Rosselli — Gentleman Gangster,… Read More: Meet the Mafia gangster the CIA wanted to assassinate Fidel… »

Intermittent Fasting No Better Than Other Calorie Restriction Diets

Scientists have concluded that intermittent fasting, also referred to as the 5:2 diet or the 16:8 diet, does help with weight loss, but it’s no better than conventional calorie restriction diets for losing weight. An example of an intermittent fasting diet is feasting for 8 hours and then fasting for 16 hours. Some intermittent fasting… Read More: Intermittent Fasting No Better Than Other Calorie Restriction Diets »

American Medical Association report shows competition shrinking in many U.S. health insurance markets

Competition in commercial health insurance markets is shrinking for half the country. That’s the word from the American Medical Association‘s “Competition in Health Insurance: A Comprehensive Study of U.S. Markets” report. The findings showed half of all states had commercial health insurance markets that were less competitive in 2017 than in 2016. The report offers… Read More: American Medical Association report shows competition shrinking in many U.S.… »

FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation

FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation Print this page November 28, 2018 — The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved… Read More: FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with… »